Display search results for ** instead (3 products)
31 Jan 2020  |  South Asia, Middle East & North Africa
Pharmaceuticals and Digital Health Account for Around 75% of Revenue and Drive Growth
GCC accounts only for 1.2% of the global HC revenue, but it is the region that saw the highest growth rate in the last decade. GCC has opened doors to global suppliers and moved beyond US imports, which is likely to be the game changer in the 2020s. Technology and digitization are in higher demand than ever before because of higher awareness and ...
17 Apr 2020  |  South Asia, Middle East & North Africa
The Extent of Privatization, Localization, and Digitalization will Determine the Future of the KSA Healthcare Market
Amid the volatility in oil prices and dampened global economic growth due to the outbreak of COVID-19, the Kingdom of Saudi Arabia (KSA) healthcare market is expected to grow to $16.1 billion in value at 8.8Percentage in 2020. KSA’s pharmaceutical and MedTech markets are primarily import driven, therefore the impact of COVID-19 cannot be measured...
23 Aug 2019  |  South Asia, Middle East & North Africa
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...
USD 4,455.00 save 10 %